2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$4.51+$0.09 (+2.04%)
Price as of Sep 11, 2026 7:37 PM EDT- $262.5MMarket Cap
- -14.84%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$4.51+$0.09 (+2.04%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.42 | ||
Change | -$0.07 (-1.56%) | ||
Open | $4.54 | ||
High | $4.62 | ||
Low | $4.37 | ||
Previous Close | $4.49 | ||
Volume | 289,027 | ||
30-Day Average Volume | 377,006 | ||
1-Week Change | -10.16% | ||
1-Month Change | -32.93% | ||
1-Year Change | -14.84% | ||
3-Year Change | -41.61% | ||
5-Year Change | -68.25% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $203.4M | ||
Market Cap | $262.5M | ||
Enterprise Value | $194.4M | ||
Period: QTR TTM FY | |||
Revenue | $16.1M | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$17.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $119.5M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -3 | ||
P/E | -44 | ||
PEG | -1 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue